Generic name:(oral) atomoxetineBrand names:,Other brand names:Drug class:
Medically reviewed by. Last updated on Mar 23, 2024.
Atomoxetine is used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adults. It is also used to help control weight when prescribed for other indications.
Atomoxetine is not approved for use in children. This medicine may be prescribed for other uses; ask your doctor or pharmacist for more information.
Atomoxetine is used to treat ADHD and is approved by the Food and Drug Administration (FDA) for the treatment of ADHD symptoms in children and adolescents.
Atomoxetine may be used alone or in combination with other medications to treat ADHD. The drug is not approved for use in children under 6 years of age. This medicine may be used for treatment of other conditions, such as anxiety, depression, or a family history of ADHD.
Atomoxetine is not approved to treat any other types of neurodevelopmental disorders. This medicine may be used for other conditions as well.
Tell your doctor if you have any of these conditions:
If you are pregnant or plan to become pregnant, discuss with your doctor before starting treatment with atomoxetine. This medicine may harm the fetus or infant.
Tell your doctor if you are breastfeeding. The amount of acid that the infant has is unknown. This medicine passes through breast milk and may affect the infant's health.
This medicine can cause serious side effects. Your doctor or pharmacist will be able to tell you which is more likely.
Tell your doctor if you have any questions about why this medicine has been prescribed for you.
Tell your doctor or pharmacist any concerns you have about your medicine or whether any new side effects may occur. Your doctor or pharmacist will be able to tell you whether any new problems are the cause of your symptoms.
Tell your doctor if you are pregnant or plan to become pregnant. Your doctor will discuss the benefits and risks of using atomoxetine during pregnancy.
Atomoxetine may affect the developing baby if you use it during pregnancy. You should not breast-feed while using this medicine.
Tell your doctor or pharmacist if you are taking any other medicines, including any that you get online from a pharmaceutical company.
Take this medicine exactly as your doctor or pharmacist has told you. Do not skip doses or stop taking it early, even if you start to feel better or feel better. Take as directed by your doctor or pharmacist, usually once daily.
Atomoxetine is usually taken once daily.
Use this medicine for the full prescribed length of time, even if you start to feel better. Check with your doctor if you have questions or concerns about using this medicine.
Tell all your health care providers that you are using atomoxetine.
Get emergency medical help if you havesigns of an allergic reaction to Atomoxetine: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur but not everyone will experience them.
ADHD (Anxiolytic and Hyperthyroidism) is a condition in which the brain’s neurons produce a chemical called ADHD medication, called norepinephrine. In people with ADHD, norepinephrine is a neurotransmitter that is primarily involved in regulating attention, memory, and emotional regulation. The medication affects both the frontal and temporal lobes of the brain, and in its absence it can trigger either hyperactive or impulsive behavior.
The medication has also been shown to improve the ability to concentrate, speed up the processing of tasks and increase focus, and to decrease the volume of attention span in patients with ADHD. It is commonly prescribed for patients who have trouble falling asleep or sleeping, and for patients with bipolar disorder. ADHD medications can also improve attention span and overall executive function in patients with bipolar disorder, and help to prevent relapse in patients with bipolar disorder.
In patients with ADHD, the medication increases the amount of norepinephrine, which is the neurotransmitter involved in regulating attention and memory, in the brain, as well as its effects on impulsivity and hyperactivity. However, it is unknown whether this medication can increase the levels of norepinephrine in the brain, as does a drug that also contains norepinephrine. In addition, studies have shown that the drug can affect the levels of other neurotransmitters, such as dopamine, while it does not affect dopamine levels. It is therefore unknown whether ADHD medications like Strattera are associated with a greater risk of developing depression. In a study published in theBritish Journal of Psychiatry, researchers looked at the effects of Strattera in a group of patients with ADHD who were taking a combination of methylphenidate (Ritalin) and norepinephrine-dopamine reuptake inhibitors (dapoxetine, Pamelor).
They found that Strattera increased levels of norepinephrine in the prefrontal cortex of patients, and the levels of norepinephrine were increased in patients with ADHD. The researchers said this finding is consistent with the findings in patients with ADHD, and the combination of Strattera and norepinephrine-dopamine reuptake inhibitors has been shown to improve attention span and impulsivity in patients with ADHD.
The researchers said that in addition to norepinephrine, Strattera can affect the levels of other neurotransmitters, including dopamine, histamine, norepinephrine, serotonin, and dopamine, as well as the levels of other neurosteroids, including norepinephrine and serotonin. The study found that Strattera did not cause an increase in the levels of these neurotransmitters, nor did it increase their levels.
In a separate study, the researchers also looked at the effects of Strattera on the levels of norepinephrine and dopamine in patients with ADHD. They found that Strattera did not affect the levels of these neurotransmitters, nor did it cause an increase in their levels. The researchers also looked at the effects of norepinephrine on the levels of serotonin and dopamine, as well as on the levels of norepinephrine and serotonin. Strattera did not affect the levels of these neurotransmitters.
They also found that Strattera does not cause an increase in the levels of serotonin or norepinephrine in patients with ADHD. They found that Strattera increased levels of serotonin and norepinephrine in patients with ADHD, and that this effect was not associated with a decrease in their levels. The researchers also looked at the effects of Strattera on the levels of dopamine, histamine, norepinephrine, and serotonin.
They concluded that Strattera does not affect the levels of these neurotransmitters, nor do it increase the levels of other neurosteroids, nor the levels of serotonin and dopamine.
Strattera has also been shown to improve attention span in patients with ADHD. Strattera has been shown to improve the ability to remember complex tasks and to reduce the severity of symptoms associated with ADHD. It has also been shown to improve attention span in patients with attention deficit hyperactivity disorder (ADHD).
In addition to the aforementioned studies, Strattera has been used in the treatment of ADHD, as well as to treat other conditions, such as polypharmacy and the use of medication to address ADHD symptoms. The medication is available in both oral and injectable forms.
In addition to Strattera, a company called TMS, is developing a medication called Strattera for patients with ADHD. The company is also working with pharmaceutical companies, including Novartis and Eli Lilly, to develop a treatment that works best for patients with ADHD.
Strattera 150mg capsules
'Strattera 150mg Capsules' You will get the credit card for you!
This medicine is a Prescription Only Medicine (S4) and is dispensed under a doctor's prescription. The generic version of Strattera isextended-ONLY®. Prescriptions have been authorised for this medicine if the name of the medication is correct.
It is a prescription-only medicine (CGP) used to treat attention-deficit hyperactivity disorder (ADHD) and other mental health conditions. It is used to treat symptoms of attention-deficit hyperactivity disorder (ADHD) such as difficulty paying attention, poor concentration and/or unable to pay attention. Strattera can cause severe side effects such as headaches, nausea, vomiting, irritability, flushing, dizziness, heartburn, dry mouth, drowsiness and/or trouble sleeping.
Cautiously call your doctor if you have any information about any potential CGP side effects that you would like before you buy Strattera.
Strattera 150mg Capsules act on the part of foremails and text receptors in the brain to increase the time it takes to think and absorb information from one another. It may also increase alertness, improve concentration and/or attention, improve concentration and/or focus, improve impulse control and/or stop hyperactivity. Strattera is used to treat symptoms of attention-deficit hyperactivity disorder (ADHD) such as difficulty paying attention and poor concentration and/or unable to pay attention.
Strattera 150mg Capsules can cause some side effects. Common side effects of Strattera may include:
If you experience any severe or concerning side effects, you should stop taking this medicine and contact your doctor immediately.
Yes! You can buyfrom our online pharmacy at an affordable price. Our pharmacy is registered with the General Pharmaceutical Council (GPhC)
The price of Strattera 150mg capsules is£16.99per dose.
If you take Strattera more than£1.00, you may face a withdrawal reaction such as headaches, dizziness and flushing.
Strattera is a prescription-only medicine used to treat attention-deficit hyperactivity disorder (ADHD) and certain other mental health conditions. It is used to treat symptoms of attention-deficit hyperactivity disorder (ADHD) such as difficulty paying attention and poor concentration and/or inability to pay attention. Strattera is prescribed for the treatment of symptoms of attention-deficit hyperactivity disorder (ADHD) such as:
Strattera 150mg capsules may also be used for the treatment of narcolepsy. You may also benefit from taking Strattera 150mg capsules for insomnia. You should not take Strattera if you are taking other types of medication such as non-stimulants such as alcohol, drugs for sleeping or sleeping disorder (Nisdexamfetamine), sleeping medications or other stimulants such as amphetamine.
Yes, Strattera 150mg capsules may cause drowsiness.
Brand Name(s):Strattera, Adderall, Atomoxetine
Generic Name(s):Atomoxetine
Drug Class:Atypical 5-HT1A Antagonist
How it Works
Atomoxetine, a selective non-selective norepinephrine reuptake inhibitor, is used to treat attention-deficit hyperactivity disorder (ADHD) and other disorders associated with hypertonia. It works by increasing the amount of norepinephrine available in the brain.
Atypical 5-HT1A agents are a type of selective norepinephrine reuptake inhibitor. They work by blocking the reuptake of norepinephrine in the brain.
Atomoxetine is usually prescribed for ADHD, but it may also be prescribed for other conditions.
For details, see section 4.2.
Dosage
Drug Class
Atomoxetine is available in a generic form called atomoxetine. Atomoxetine is a selective norepinephrine reuptake inhibitor.
For details, see section 4.3.
Uses
Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD).
Atomoxetine belongs to a group of medicines called norepinephrine reuptake inhibitors.
Atomoxetine increases the amount of norepinephrine available in the brain. It also increases the amount of norepinephrine in the synapses. This leads to increased activity in the brain. The drug is typically used alone or with other medicines, and may be used with other stimulant treatments.
It is also used as a monotherapy in combination with other medicines.
Drug Interactions
Atomoxetine may interact with certain medicines.
Contraindications
Atomoxetine is contraindicated in patients with a history of hypersensitivity to atomoxetine or any component of the medication.
Side Effects
The most common side effects of atomoxetine include dizziness, nausea, diarrhea, and dry mouth.
Warnings
Atomoxetine should be used with caution in patients with a history of hypersensitivity to any component of the medication.
It is not known whether atomoxetine is safe for use in patients who have had a severe allergic reaction to atomoxetine or other medicines. Patients with a history of hypersensitivity to the active ingredient (methylenedioxymeth-5-ene-1,2-diol) should not take this medication.
Atomoxetine can be given with other stimulant medicines, and atomoxetine may cause drowsiness or dizziness. Patients should take this medication with alcohol or food.
For more information, see section 4.4.
Atomoxetine should not be used for the treatment of ADHD.
Atomoxetine should not be used in patients with a history of hypersensitivity to any component of the medication.
Stade de France Pharmacy